latest news releases from the newsroom
MorphoSys AG Reports Strong Financial Results for Fiscal Year 2008
MARTINSRIED, Germany, Feb. 26, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment; TecDAX) today announced its financial results according to International Financial Reporting Standards (IFRS) for the three-months' period and financial year ending December 31, 2008. The Company achieved Group revenues of EUR 71.6 million (2007: EUR 62.0 million) and more than doubled its operating profit to EUR 16.4 million (2007: EUR 7.0 million). The Research Antibodies segment AbD made the all-important transition to profitability in 2008. Group net profit after taxes increased to EUR 13.2 million (2007: EUR 11.5 million). At the end of the year 2008 MorphoSys's cash position amounted to EUR 137.9 million (2007: EUR 106.9 million).
Guotai Asset Management Signs Exclusive Agreement for NASDAQ-100 Index(r) in China
NEW YORK and SHANGHAI, China, Feb. 26, 2009 (GLOBE NEWSWIRE) -- Guotai Asset Management and The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that Guotai has executed an exclusive licensing agreement with NASDAQ OMX to use the NASDAQ-100 Index in the development of an exchange traded product in China. The announcement comes as demand for indexed overseas products in China is rapidly developing. Subject to regulatory approval, this NASDAQ-100 Index-linked product will be the first foreign index-linked financial product traded in China.